Search filters

List of works by Daniela E. Oprea-Lager

A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems

scientific article published on 18 February 2015

A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer

scientific article published in May 2024

A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers

scientific article published on 18 April 2024

A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial

scientific article

ABCC4 Decreases docetaxel and not cabazitaxel efficacy in prostate cancer cells in vitro

scientific article published on February 1, 2013

Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT Studies.

scientific article

Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?

scientific article published on 15 December 2018

Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT.

scientific article published on 29 March 2017

Biochemical Persistence of Prostate-specific Antigen after Robot-assisted Laparoscopic Radical Prostatectomy: Tumor localizations using PSMA PET/CT imaging

scientific article published on 06 November 2020

Clinical value of myocardial perfusion scintigraphy as a screening tool in liver transplant candidates

scientific article published in March 2011

Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer

scientific article published on 06 October 2020

Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

scientific article published on 02 July 2020

Correction to: Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake

scientific article published on 01 February 2020

Cylindroma, an uncommon presentation on 18F-DCFPyL PET/CT

scientific article published on 11 July 2020

Detection of Recurrent Prostate Cancer Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients not Meeting the Phoenix Criteria for Biochemical Recurrence After Curative Radiotherapy

scientific article published on 19 February 2020

Detection of intraprostatic tumour localisation with 18F-PSMA PET/CT compared to radical prostatectomy specimens: Is PSMA-targeted biopsy feasible? –the DeTeCT trial– ⬇️

scholarly article

Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial

scientific article published on 20 October 2020

Dual-phase PET-CT to differentiate [18F]Fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancer

scientific article

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

scientific article published on 07 November 2020

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer

scientific article published on 07 October 2020

Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer

scientific article published on 22 June 2019

Early lesion detection with 18F-PSMA (DCFPyL) PET/CT in 248 patients with biochemically recurrent prostate cancer ⬇️

scholarly article

Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non–Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review

scientific article published in 2022

First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PET

scholarly article

Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting

scientific article published in 2023

Healthy Tissue Uptake of 68Ga-Prostate-Specific Membrane Antigen, 18F-DCFPyL, 18F-Fluoromethylcholine, and 18F-Dihydrotestosterone

scientific article published on 10 January 2019

Impact of the COVID-19 crisis on imaging in oncological trials

scientific article published on 12 June 2020

Impact van de 18F-DCFPyL PET/CT-scan op het behandeladvies voor patiënten met prostaatkanker en een biochemisch recidief na curatieve therapie

scientific article published on 2 July 2021

Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0-1 non-small cell lung cancer: the INCREASE trial

scientific article published on 14 August 2020

Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for 18F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer

scientific article published on 03 September 2019

Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake

scientific article published on 01 February 2020

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

scientific article published on 14 September 2020

Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer

scientific article published on 31 July 2020

Management impact of 18F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study

scientific article published on 5 February 2021

Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers

scientific article published on 13 January 2021

Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting

scientific article published on 07 August 2019

PET-Guided Stereotactic Irradiation of Prostate Cancer Lymph Node Metastases

scientific article published on 18 August 2016

PSMA PET/CT in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer

scientific article published on 18 November 2020

Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial

scientific article published on 12 August 2020

Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics

scientific article published on 11 September 2024

Prognostic Value of [ 18 F]-Fluoromethylcholine Positron Emission Tomography/Computed Tomography Before Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer

scientific article published on 13 February 2018

Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.

scientific article

Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer

scientific article published on 14 February 2020

Quantitative implications of the updated EARL 2019 PET-CT performance standards

scientific article published on 26 December 2019

Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review

scientific article

Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer

scientific article published on 10 January 2020

Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer

scientific article published on 23 December 2015

Reply by Authors

scientific article published in April 2021

Reply: Quantification of 18F-DCFPyL Uptake: TBR Versus Patlak's Analysis

scientific article published on 26 August 2019

Sensitivity of 18F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer

scientific article published on 30 July 2019

Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer

scientific article published on 18 April 2019

Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group.

scientific article published on 10 January 2018

The Impact of Omitting Contralateral Systematic Biopsy on the Surgical Planning of Patients with a Unilateral Suspicious Lesion on Magnetic Resonance Imaging Undergoing Robot-assisted Radical Prostatectomy for Prostate Cancer

scientific article published in May 2024

The Phoenix criteria for biochemically recurrent prostate cancer after curative radiotherapy appear obsolete in the era of prostate-specific membrane antigen PET: A plea for urgent re-evaluation of current guidelines ⬇️

scholarly article

The Predictive Value of Preoperative Negative Prostate Specific Membrane Antigen Positron Emission Tomography Imaging for Lymph Node Metastatic Prostate Cancer

scientific article published in June 2021

The Predictive Value of Preoperative Negative Prostate Specific Membrane Antigen Positron Emission Tomography Imaging for Lymph Node Metastatic Prostate Cancer

The accuracy and intra- and interobserver variability of PSMA PET/CT for the local staging of primary prostate cancer

scholarly article

The appropriateness of PSMA PET/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients—towards a tumor volume-based risk stratification

scientific article published on 23 September 2024

The navigating and de-risking role of <sup>89</sup>Zr-immuno-PET in the development of biopharmaceuticals

scientific article published on 04 December 2020

The oncological characteristics of <scp>non‐prostate‐specific membrane antigen (PSMA)‐expressing</scp> primary prostate cancer on preoperative <scp>PSMA</scp> positron emission tomography/computed tomography

The oncological characteristics of <scp>non‐prostate‐specific membrane antigen (PSMA)‐expressing</scp> primary prostate cancer on preoperative <scp>PSMA</scp> positron emission tomography/computed tomography

scientific article published on 30 September 2022

The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.

scientific article

Tumorlokalisaties op PSMA-PET/CT bij patiënten met een persisterend meetbaar PSA na een radicale prostatectomie

scientific article published on 9 March 2021

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group

scientific article published on 01 October 2018

Verification of 18F-Prostate-Specific Membrane Antigen PET/CT detected lesions - A systematic assessment of the positive predictive value in patients with biochemically recurrent prostate cancer ⬇️

scholarly article

Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study

scientific article published on 30 March 2014

[18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study

scientific article published in 2023

[18F]fluoromethylcholine as a chemotherapy response read-out in prostate cancer cells

scientific article

Paulina is supported by:

About Paulina

Help